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In recent decades, epidemiological and experimental research has yielded plenty of evidence that air pollution exposure is a key risk factor for asthma flare-ups and, potentially, new cases. 1, 2 A study in Environmental Health Perspectives offers the first estimates of the global asthma burden that may be attributable to specific air pollutants. 3 Although preliminary, the authors' conclusions are sobering. They estimated that in 2015, some 9-23 million asthma-induced emergency room visits worldwide resulted from ozone exposure, 5-10 million resulted from fine particulate matter (PM 2:5 ) exposure, and 400,000-500,000 resulted from nitrogen dioxide (NO 2 ) exposure.
These figures are subject to numerous assumptions and uncertainties, the authors stress. They also are not mutually exclusive or designed to be combined; most epidemiological studies informing the estimates assessed single pollutants without controlling for the others, explains lead author Susan Anenberg, a professor of environmental and occupational health at George Washington University. "We do not know whether there's a whole lot of overlap or any overlap; maybe there's none," she says. "We just really do not know."
Despite this and other limitations, the paper represents an important step forward for the field, says John Balmes of the University of California, San Francisco, an expert on the respiratory health effects of various air pollutants. "I think it is a major contribution to the global burden of disease effort," says Balmes, who was not involved with the study. "I always felt bad, as somebody who has done research on air pollution and asthma for a long time, that morbidity that I knew was related to air pollution was not considered in the burden-of-disease risk assessment."
To assess the impact of air pollution on asthma-related emergency room visits, the researchers first had to know how many asthma-related visits there are in total. That number did not exist, so they had to estimate it, Anenberg says. The team used survey data from 54 countries plus Hong Kong to estimate national and regional emergency room visitation rates among asthma patients in 2015. Extrapolation to the rest of the planet yielded a calculation of 116 million asthma-related visits worldwide that year.
In 2015, exposures to ozone and PM 2:5 were estimated to contribute to 8-20% and 4-9% (respectively) of asthma-related emergency room visits worldwide. NO 2 was estimated to play a smaller role, contributing to only 0.4% of visits. Image: © ZUMA Press, Inc./Alamy Stock Photo.
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The next step was to assess the pollution-attributable fraction of asthma-related visits. The authors turned to meta-analyses of epidemiological studies covering 27 countries in North America, Europe, Asia, and Latin America for estimates of concentrationresponse factors. Essentially, these studies predicted the relative risk of asthma exacerbation at various concentrations of ozone, PM 2:5 , and NO 2 . Finally, the authors combined these data sets with known asthma incidence and prevalence rates, population data, and air pollution maps that incorporated data from modeling, remote sensing, and in situ monitoring.
The authors estimated that approximately 37% of ozone-related visits and 73% of PM 2:5 -related visits were attributable to anthropogenic emissions. The rest, they concluded, were likely due to naturally occurring pollution, although they point out that some of natural sources (for instance, dust storms) can be influenced by human activity.
Of the three pollutants addressed in this study, NO 2 and PM 2:5 had the strongest associations with new-onset asthma. Evidence for NO 2 as a risk factor has been reported fairly consistently among all age groups, whereas the evidence for PM 2:5 is mixed and has been limited to pediatric cases. When the investigators assessed the potential contribution of NO 2 and PM 2:5 to development of new asthma cases, they concluded that concentrations above natural background levels may be responsible for one-third of all new pediatric cases each year.
One of the study's central limitations, which the authors address directly, is that its calculation of global visitation rates relies on a number of major assumptions. "The health care reporting systems for each of these countries are different," Balmes notes. "It is difficult to be sure that they are capturing the same thing in every jurisdiction."
In addition, emergency room visits are not the perfect surrogate for asthma exacerbation-and they likely underrepresent the scope of the problem, given that many flare-ups can be managed at home. 4 "Some patients will call their doctor, and the doctor will tell them to take more medication, or they will visit the doctor," Balmes says. "But most people will not be reporting to the emergency room."
